Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial
Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial
Snehal Palwe, Monica Gupta, Piotr Iwanowski, Balaji Veeraraghavan et al.
Citations
1 citations
Journal
The Lancet Regional Health - Southeast Asia
Topics
Pneumonia and Respiratory Infections
Field-Weighted Citation Impact (FWCI)
1.35
article
Efficacy and safety of a 3-day once-daily regimen of oral nafithromycin in comparison to oral moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults: a phase III, randomized, double-blind controlled trial
The Lancet Regional Health - Southeast AsiaVol. 41
Institutions
Christian Medical College, Vellore (IN), Axis Multispecialty Hospital (IN), Wockhardt (India) (IN), Christian Medical College (IN), Samvedna Hospital (IN)